Nermina Alagic
Overview
Explore the profile of Nermina Alagic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pusuroglu H, Somuncu U, Bolat I, Akgul O, Yildirim H, Ozbay Ozyilmaz S, et al.
Arch Med Sci
. 2020 Nov;
16(6):1346-1352.
PMID: 33224333
Introduction: Obstructive sleep apnea (OSA) and endothelial dysfunction are associated with cardiovascular risk factors and the development of atherosclerosis. Endocan is a marker of endothelial dysfunction, while obstructive sleep apnea...
2.
Arisha M, Hsiung M, Nanda N, Serkan B, Ahmad A, Elkaryoni A, et al.
Echocardiography
. 2017 Nov;
34(11):1680-1686.
PMID: 29086433
Ventricular septal rupture is a serious complication following acute myocardial infarctions and is associated with a significant mortality rate. Classically, two-dimensional transthoracic echocardiography has been used to diagnose this complication...
3.
Elsayed M, Bulur S, Kalla A, Ahmed M, Hsiung M, Uygur B, et al.
Echocardiography
. 2016 Aug;
33(8):1234-8.
PMID: 27550532
We present two cases in whom live/real time three-dimensional transesophageal echocardiography (3DTEE) provided incremental value in the assessment of atherosclerotic disease in the aorta. In one patient, it identified additional...
4.
Ayhan E, Isik T, Ghannadian B, Akgul O, Alagic N
Minerva Cardioangiol
. 2014 Dec;
64(4):367-74.
PMID: 25516137
Background: We observed the effect of culprit artery in patients undergoing primary percutaneous coronary intervention (PCI) caused by inferior wall ST elevation myocardial infarction (STEMI) during hospital stay and 6-month...
5.
Anbil S, Rizvi I, Celli J, Alagic N, Pogue B, Hasan T
J Biomed Opt
. 2014 May;
18(9):098004.
PMID: 24802230
Common methods to characterize treatment efficacy based on morphological imaging may misrepresent outcomes and exclude effective therapies. Using a three-dimensional model of ovarian cancer, two functional treatment response metrics are...
6.
Rizvi I, Gurkan U, Tasoglu S, Alagic N, Celli J, Mensah L, et al.
Proc Natl Acad Sci U S A
. 2013 May;
110(22):E1974-83.
PMID: 23645635
Seventy-five percent of patients with epithelial ovarian cancer present with advanced-stage disease that is extensively disseminated intraperitoneally and prognosticates the poorest outcomes. Primarily metastatic within the abdominal cavity, ovarian carcinomas...
7.
Rizvi I, Anbil S, Alagic N, Celli J, Celli J, Zheng L, et al.
Photochem Photobiol
. 2013 Feb;
89(4):942-52.
PMID: 23442192
The successful implementation of photodynamic therapy (PDT)-based regimens depends on an improved understanding of the dosimetric and biological factors that govern therapeutic variability. Here, the kinetics of tumor destruction and...